FIG. 7.
EIAVvMA-1c enters eUVEC through clathrin-mediated endocytosis. eUVEC were treated with MβCD for 1 h and infected with EIAVMA-1 or EIAVvMA-1c or transduced with VSV-G- or EBOV-pseudotyped particles (A). eUVEC were treated with CPZ for 1 h and infected with EIAVMA-1 or EIAVvMA-1c or transduced with VSV-G-pseudotyped EIAV particles (B). Cells were stained 40 h after infection and compared to the number of infected cells when particles were treated with the control. Data represent the averages and standard errors of three experiments performed in triplicate. *, P < 0.05; **, P < 0.001.